Press Releases October 6, 2026 04:30 PM

Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026

Merit Medical Systems Schedules Q3 2026 Earnings Release and Investor Call for October 29, 2026

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
MMSI

Merit Medical Systems, Inc., a global leader in healthcare technology, announced it will report its third quarter 2026 financial results after market close on October 29, 2026. The company will hold an investor conference call and webcast on the same day to discuss the results. Merit specializes in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures across various medical sectors including cardiology and oncology.

Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026
MMSI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Merit Medical Systems to announce Q3 2026 earnings on October 29 after market close.
  • Investor conference call and webcast scheduled for the same day at 4:30 p.m. Eastern Time.
  • Company focuses on medical devices used in interventional, diagnostic, and therapeutic procedures impacting healthcare technology and medical device sectors.

SOUTH JORDAN, Utah, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2026, after the close of the stock market on Thursday, October 29, 2026. Merit plans to hold its investor conference call on the same day (Thursday, October 29, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).

To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details.

A live webcast and slide deck can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at www.merit.com.

ABOUT MERIT

Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling approximately 900 individuals. Merit employs approximately 7,500 people worldwide.

Contacts:

 PR/Media Inquiries:
Sarah Comstock
Merit MedicalInvestor Inquiries:
Mike Piccinino, CFA, IRC
ICR Healthcare+1-801-432-2864+1-443-213-0509sarah.comstock@[email protected]

Risks

  • Market and operational performance may impact financial results, which will be revealed during the earnings call.
  • Potential industry-specific regulatory or supply chain risks could affect the company's performance.
  • Economic conditions impacting healthcare spending and investment could influence Merit Medical's future outlook.

More from Press Releases

Harmony Biosciences to Participate in Upcoming Investor Conferences Nov 19, 2026 Pure Cycle Announces Record Financial Results For the Year Ended August 31, 2026 Nov 18, 2026 Sachem Capital Reports Third Quarter 2026 Results Nov 16, 2026 Inter&Co Delivers Record 3Q26 Net Income of US$76.1 Million, With Strong Growth, Higher Margin and Better Efficiency Nov 12, 2026 Super League to Report Third Quarter 2026 Financial Results on Monday, November 16, 2026 Nov 12, 2026